Angiotensin Receptor Neprilysin Inhibition Across Ejection Fraction and Acuity Spectra in Heart Failure

JACC Heart Fail. 2024 Mar;12(3):583-587. doi: 10.1016/j.jchf.2023.11.021. Epub 2024 Jan 24.

Authors

Peder L Myhre¹, Carolyn S P Lam²

Affiliations

¹ Department of Cardiology, Division of Medicine, Akershus University Hospital, Lørenskog, Norway; K.G. Jebsen Center for Cardiac Biomarkers, Institute of Clinical Medicine, University of Oslo, Norway.
² National Heart Centre Singapore, Singapore; Duke-National University of Singapore, Singapore. Electronic address: Carolyn.lam@duke-nus.edu.sg.

PMID: 38276934
DOI: 10.1016/j.jchf.2023.11.021

No abstract available

Keywords: HFpEF; acute heart failure; angiotensin receptor neprilysin inhibitor; heart failure; sacubitril/valsartan.

Publication types

Editorial

MeSH terms

Aminobutyrates / therapeutic use
Angiotensin Receptor Antagonists / pharmacology
Angiotensin Receptor Antagonists / therapeutic use
Angiotensins
Drug Combinations
Heart Failure* / drug therapy
Humans
Neprilysin
Receptors, Angiotensin
Stroke Volume
Tetrazoles / therapeutic use
Valsartan

Substances

Angiotensins
Neprilysin
Receptors, Angiotensin
Valsartan
Tetrazoles
Aminobutyrates
Drug Combinations
Angiotensin Receptor Antagonists